Powered by RND
PodcastsNegóciosThe Readout Loud
Ouça The Readout Loud na aplicação
Ouça The Readout Loud na aplicação
(1 079)(250 081)
Guardar rádio
Despertar
Sleeptimer

The Readout Loud

Podcast The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Episódios Disponíveis

5 de 352
  • 348: Cuts, ousters and drama at the FDA
    STAT’s FDA reporter Lizzy Lawrence joins to discuss her inside-the-agency reporting on how Robert F. Kennedy Jr. forced top FDA officials to resign at a time when newly sworn-in FDA Commissioner Makary is still figuring out how to get around the agency’s White Oak campus in suburban Maryland. Then: AstraZeneca presented positive mid-stage results this week on a PCSK9 pill that dramatically lowered cholesterol levels on top of traditional statins. R&D executive Sharon Barr joins to talk about why AstraZeneca views this experimental cardiovascular medicine as a key part of its growth strategy.
    --------  
    31:10
  • 347: More HHS upheaval, 23andMe's bankruptcy, and AI for cancer survival
    Adam, Elaine, and Allison discuss the Trump administration’s plan for huge job cuts and a restructuring of the country’s top health care agencies, the approval of the first drug to treat a devastating rare disease, and the bankruptcy of 23andMe. Then, they bring on the chief executive of startup Altis Labs to discuss new data from a study they conducted with AstraZeneca on an AI tool for cancer drug development.
    --------  
    31:25
  • 346: Zealand's obesity strategy and Immunovant's curious development plan
    We chat about positive data from Immunovant's autoimmune drug candidate, a patient death linked to Sarepta's gene therapy, and dispatches from our STAT Breakthrough Summit East in New York. We also bring on Zealand Pharma CEO Adam Steensberg to talk about his company’s amylin-targeting obesity treatment, the partnership deal it recently signed with Roche, and his thoughts on the industry's intense focus on weight loss.
    --------  
    42:34
  • 345: The sudden withdrawal of a CDC nominee and what went wrong with Covid policies
    We bring on our colleague Sarah Owermohle to discuss the White House's sudden move to withdraw the nomination of Dave Weldon as its pick to run the CDC just hours before Weldon's confirmation hearing. It's also the five-year anniversary of the Covid-19 pandemic. We chat with Princeton political scientist Frances Lee about a new book she co-authored that offers an unflinching assessment of the U.S. policy responses to the pandemic and raises some provocative questions about what went wrong.
    --------  
    31:00
  • 344: Trump's FDA commissioner nominee takes the hot seat
    Will Marty Makary be confirmed as the next commissioner of the Food and Drug Administration? Will he bring back employees laid off by DOGE? And what did he get wrong during his confirmation hearing? We discuss all that and more during this week's special episode.
    --------  
    25:51

Mais podcasts de Negócios

Sobre The Readout Loud

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Sítio Web de podcast

Ouve The Readout Loud, The Diary Of A CEO with Steven Bartlett e muitos outros podcasts de todo o mundo com a aplicação radio.pt

Obtenha a aplicação gratuita radio.pt

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções

The Readout Loud: Podcast do grupo

Aplicações
Social
v7.13.1 | © 2007-2025 radio.de GmbH
Generated: 4/4/2025 - 7:43:41 PM